Anthony Yiu‐Ho Woo

Shenyang Pharmaceutical University — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

21h-index1.5kcitations43works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Receptor Mechanisms and Signaling(26), Pharmacological Effects and Assays(12), Cardiac electrophysiology and arrhythmias(10), Asthma and respiratory diseases(5), Neuroscience and Neuropharmacology Research(5)

Publications43 total

Functional Features of Senescent Cells and Implications for Therapy
International Journal of Molecular Sciences·2025· 3 citedOpen Access
Stimulator of interferon genes is required for Toll-Like Receptor-8 induced interferon response
2023Open Access
Cardiac β-Adrenoceptor Signaling: The New Insight on An Old Target in the Therapy of Cardiovascular Disease
International Journal of Drug Discovery and Pharmacology·2022· 6 citedOpen Access
Discovery of a Highly Selective β<sub>2</sub>-Adrenoceptor Agonist with a 2-Amino-2-phenylethanol Scaffold as an Oral Antiasthmatic Agent
Journal of Medicinal Chemistry·2022· 5 citedOpen Access
8-Hydroxyquinolin-2(1H)-one analogues as potential β2-agonists: Design, synthesis and activity study
European Journal of Medicinal Chemistry·2021· 3 citedOpen Access
Recent Advances in β<sub>2</sub>-Agonists for Treatment of Chronic Respiratory Diseases and Heart Failure
Journal of Medicinal Chemistry·2020· 18 citedOpen Access
Heterodimerization With 5-HT <sub>2B</sub> R Is Indispensable for β <sub>2</sub> AR-Mediated Cardioprotection
Circulation Research·2020· 38 citedOpen Access
Design, synthesis and biological evaluation of 8-(2-amino-1-hydroxyethyl)-6-hydroxy-1,4-benzoxazine-3(4H)-one derivatives as potent β2-adrenoceptor agonists
Bioorganic & Medicinal Chemistry·2019· 12 citedOpen Access
A New Series of G <sub>s</sub> ‐ and β‐Arrestin‐biased β <sub>2</sub> ‐Adrenoceptor Agonists
The FASEB Journal·2019
Discovery of β-arrestin-biased β2-adrenoceptor agonists from 2-amino-2-phenylethanol derivatives
Acta Pharmacologica Sinica·2019· 11 citedOpen Access
Design, synthesis and biological evaluation of 5-(2-amino-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one derivatives as potent β2-adrenoceptor agonists
Bioorganic & Medicinal Chemistry·2018· 16 citedOpen Access
ADRB2 polymorphism Arg16Gly modifies the natural outcome of heart failure and dictates therapeutic response to β-blockers in patients with heart failure
Cell Discovery·2018· 30 citedOpen Access
Synthesis and biological evaluation of β2-adrenoceptor agonists bearing the 2-amino-2-phenylethanol scaffold
European Journal of Medicinal Chemistry·2018· 14 citedOpen Access
Synthesis, biological evaluation and molecular modeling of 2-amino-2-phenylethanol derivatives as novel β2-adrenoceptor agonists
Bioorganic Chemistry·2018· 14 cited
Biased Agonism at the Angiotensin Receptor
Circulation·2017· 4 cited
GRK2/β‐arrestin mediates arginine vasopressin‐induced cardiac fibroblast proliferation
Clinical and Experimental Pharmacology and Physiology·2016· 25 cited
Vasopressin V1A receptor mediates cell proliferation through GRK2-EGFR-ERK1/2 pathway in A7r5 cells
European Journal of Pharmacology·2016· 15 cited
Interaction of β1-adrenoceptor with RAGE mediates cardiomyopathy via CaMKII signaling
JCI Insight·2016· 26 citedOpen Access
Advances in receptor conformation research: the quest for functionally selective conformations focusing on the<scp>β</scp><sub>2</sub>‐adrenoceptor
British Journal of Pharmacology·2014· 10 citedOpen Access
Biased β<sub>2</sub>‐adrenoceptor signalling in heart failure: pathophysiology and drug discovery
British Journal of Pharmacology·2014· 72 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Rui‐Ping Xiao(15), Weizhong Zhu(11), Christopher H.K. Cheng(10), Irving W. Wainer(10), Gang Xing(9), Maosheng Cheng(9), Bin Lin(7), Yuyang Zhang(7), Ying Song(6), Krzysztof Jóźwiak(6), Lucita Jimenez(6), Pan Li(6), Mary Miu Yee Waye(5), Lawrence Toll(5), Xinyue Ge(5), Rui-Ping Xiao(4), Xiaoran Li(4), Jinyan Li(4), Yongmei Mo(4), Ruijuan Xing(4)